pharma · H Pylori Infection · H. Pylori Infection · PHAT
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a pharma organization headquartered in Florham Park, USA. It trades on NYSE under ticker PHAT. Primary therapeutic focus areas include H Pylori Infection, H. Pylori Infection, Eosinophilic Esop
100 Campus Drive, Suite 102, Florham Park, New Jersey 07932, US HQ
2018 Founded
420 Employees
Public company Type
PHAT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932, US
- Founded
- 2018
- Employees
- 420
- Programs
- 11
- Drugs
- 5
- Patents
- 8
Vonoprazan
Phase 2 · small molecule · Eosinophilic Esophagitis
Vonoprazan for Eosinophilic Esophagitis is a Phase 2 program (small_molecule) at Phathom Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code EoE-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Phathom Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Eosinophilic Esophagitis
- Status
- active
- Trials
- 1